Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. For the treatment of human diseases, nasal and pulmonary routes of drug delivery are gaining increasing importance.

The Journal focuses on lipid dose forms, poorly water soluble drugs, formulation. Lipophilicity is defined as the affinity of a drug for a lipid environment. It has become a critical parameter in the Pharmaceutical industry, which indicates the relationship of a drug with their biological, pharmacokinetic, and metabolic properties. Drug delivery is the process of delivery of drugs to target sites of pharmacological actions for achieving a therapeutic effect in humans or animals. It control the rate at which a drug is released and the location in the body where it is release.

Lipid-based dose forms, which encompass a wide variety of compositional and functional characteristics, can be advantageously utilized for the formulation of lipophilic drugs. There has been a traditional reluctance to develop lipid-based dose forms due to potential problems of chemical and physical instability, and a paucity of knowledge regarding formulation design algorithms and technology transfer issues. However, there is a current resurgence of interest in lipid-based dose forms due to potential commercial and pharmaceutical benefits, and the industry trend towards the discovery/development of increasingly hydrophobic (and potent) new chemical entities. This mini-review describes some emerging formulation and biopharmaceutical strategies that hold promise for better understanding how to design and evaluate lipid-based dose forms

Best Regards,
Editorial Manager
Journal of Pharmaceutical Sciences & Emerging Drugs
Email: editor.jpsed@scitechnol.com